Summary
The ethylnitrosourea-induced cell line RG2 grows very well in infinite cell culturein vitro, and provides a simple, reproducible glioma model when inoculated into the brains of syngeneic Fischer 344 rats. We have used this tumor model in a series of therapy studies. We here report our experiences of the untreated (= tumor bearing control) animals, e.g. in terms of the techniques employed and also the growth, histology and effects upon the blood-brain barrier of the tumors. Weight loss as a measure of systemic effects during tumor development is also described. The RG2 model has considerable potential as a suitable tool for experimental neuro-oncology.
Similar content being viewed by others
References
Bigner DD, Swenberg JA; JÄnisch and Schreiber's Experimental Tumors of the Central Nervous System. The Upjohn Company, Michigan, 1977
Wechsler W, Kleihues P, Matsumoto S, Zülch KJ, Ivankovic S, Preussman R, Druckrey H: Pathology of experimental neurogenic tumors chemically induced during prenatal and postnatal life. Ann NY Acad Sci 159: 360–408, 1969
Groothuis DR, Fischer JM, Lapin G, Bigner DD, Vick NA: Permeability of different experimental brain tumor models to horseradish peroxidase. J Neuropathol Exp Neurol 41: 164–185, 1982
Groothuis DR, Fischer JM, Pasternak JF, Blasberg RG, Bigner DD: Regional measurements of blood-to-tissue transport in transplanted RG2 rat gliomas. Cancer Res 43: 3368–3373, 1983
Groothuis DR, Pasternak J, Fischer J, Blasberg RG, Bigner DD, Vick NA: Regional measurements of blood flow in experimental RG2 rat gliomas. Cancer Res 43: 3362–3367, 1983
Hossman KA, Mies G, Paschen W, Szabo L, Dolan E, Wechsler W: Regional metabolism of experimental brain tumors. Acta Neuropathol (Berl) 69: 139–147, 1986
Krajewski S, Kiwit JC, Wechsler W: RG2 glioma growth in rat cerebellum after subdural implantation. J Neurosurg 65 (2) 222–229, 1986
Wechsler W, Teske U, Reifenberger G, Deckert M, Seitz RJ, Mies G, Paschen W, Hossman K-A: Neuropathology and regional imaging of microcirculation, tissue pH, metabolites and necroses in cerebral RG2 and F98 anaplastic rat glioma transplantation tumors. In: Chatel M, Darcel F, Pecker J (eds) Brain Oncology, Martinus Nijhoff Publ Dordrecht, 1987, 187–199
Bilzer T, Reifenberger G, Wechsler W: Chemical induction of brain tumors in rats by nitrosoureas: Molecular biology and neuropathology. Neurotoxicol Teratol 11(6): 551–556, 1989
Schuepbach D, Gavin PR, Salford LG, Ceberg C, Fankhauser H: RG2 rat glioma model: influence of the blood-brainbarrier on biodistribution of boronsulfhydryl. In: Barth RF, Soloway AH (eds) Advances in Neutron Capture Therapy, Plenum Press, New York, 1993, pp 485–491
Andersson-Engels S, Brun A, Kjellén E, Salford LG, Strömblad LG, Svanberg K, Svanberg S: Identification of brain tumors in rats using laser-induced fluorescence and haematoporphyrin derivative. Lasers in Med Science 4: 241–249, 1989
Ceberg CP, Persson A, Brun A, Jergil B, Persson RBR, Salford LG: Macroscopic and microscopic biodistribution of BSH in a rat glioma model. In: Gable D, Moss R (eds) Towards Clinical Trials of Glioma with BNCT. Plenum Press, New York, 1992, pp 175–179
Ceberg C, Salford LG, Brun A, Hemler R, Persson BRR: Neutron capture imaging of10B in tissue specimens. J Radiother Oncol 26: 139–146, 1993
Aas AT, Brun A, Pero RW, Salford LG: Chlorpromazine in combination with nitrosourea inhibits experimental glioma growth. Br J Neurosurg 5: 187–192, 1994
Aas AT, Salford LG, Lönn S, Lönn U: Reduced formation of high molecular weight DNA in murine gliomas treated with nitrosourea and chlorpromazine. Anticancer Res 14: 1133–1136, 1994
Aas AT, Tönnessen TI, Brun A, Salford LG: Growth inhibition of rat glioma cellsin vitro andin vivo by aspirin. This article will be published in Journal of Neuro-Oncology 24: 171–180, 1995
Hemler R, Ceberg C, Brun A, Gable D, Persson BRR, Salford LG: A quantitative study on biokinetics and biodistribution of BSH in a rat glioma model. In: Allen BJ, Moore DE (eds) Neutron Capture Therapy for Cancer. Plenum Press, New York 1992, pp 469–472
Salford LG, Pero RW, Aas AT, Brun A: Metoclopramide as a sensitizer of 1,3-bis(2-Chloroethyl)-1-nitrosourea treatment of brain tumors in the rat. Anti-Cancer drugs 3: 267–272, 1992
Salford LG, Brun A, Eberhardt JL, Persson BRR: Experimental studies of brain tumour development during exposure to continuous and pulsed 915 MHz-radiofrequency radiation. Bioelectrochemistry and Bioenergetics 30: 313–318, 1993
Salford LG, Brun A, Eberhardt JL, Persson BRR: Experimental studies of brain tumor development during exposure to continuous and pulsed 915 MHz radiofrequency radiation. In: Martin Blank (ed) Electricity and Magnetism in Biology and Medicine, San Francisco Press Inc. 1993, pp 379–381
Salford LG, Brun A, Ceberg C, Kongstad P, Mir LM, Persson BRR: Electroporationin vivo — a new tool in the treatment of malignant brain tumors. Uppsala Journal of Medical Science. Suppl 52, p 66, 1993
Salford LG, Persson BRR, Brun A, Ceberg C, Kongstad P, Mir L: A new brain tumour therapy combining bleomycin within vivo electropermeabilization. Biochem Biophys Res Commun Vol 194, 2: 938–943, 1993
Weber DA, Ivanovic M, Franceschi D, Strand S-E, Erlandsson K, Atkins HL, Coderre JA, Susskind H, Button T, Ljunggren K: Pinhole SPECT: An approach toin vivo high resolution SPECT imaging in small laboratory animals. J Nucl Med 35: 342–348, 1994
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Aas, A.T., Brun, A., Blennow, C. et al. The RG2 rat glioma model. J Neuro-Oncol 23, 175–183 (1995). https://doi.org/10.1007/BF01059948
Issue Date:
DOI: https://doi.org/10.1007/BF01059948